Showing results (681-690 of 1,074) with videos related to

Sort By:
Pageof 108
Arteriosclerosis, Thrombosis, and Vascular Biology|April 29, 2006
Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrelDominick J Angiolillo, Antonio Fernandez-Ortiz, Esther Bernardo, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 26, 2022
The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromesAlp Aytekin, J J Coughlan, Gjin Ndrepepa, et al.
Frontiers in Medicine|June 6, 2024
Inflammation and platelet reactivity during adjunctive colchicine versus aspirin in patients with acute coronary syndrome treated with potent P2Y12 inhibitorSeung-Yul Lee, Jae Young Cho, Diana A Gorog, et al.
Journal of the American College of Cardiology|July 26, 2014
Variability of individual platelet reactivity over time in patients treated with clopidogrel: insights from the ELEVATE-TIMI 56 trialWillibald Hochholzer, Christian T Ruff, Robert A Mesa, et al.
JACC. Asia|June 12, 2026
Clopidogrel Vs Aspirin Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Nationwide Cohort StudyJun Hwan Cho, Seng Chan You, Hoseob Kim, et al.
Giornale Italiano Di Cardiologia (2006)|July 12, 2012
[Coronary stenting and surgery: perioperative management of antiplatelet therapy in patients undergoing surgery after coronary stent implantation]Roberta Rossini, Ezio Bramucci, Battistina Castiglioni, et al.
European Heart Journal|June 5, 2026
P2Y12 inhibitor monotherapy after abbreviated dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysisMarco Spagnolo, Antonino Imbesi, Costanza Agata Bordonaro, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 26, 2019
Left Ventricular Size Predicts Clinical Benefit After Percutaneous Mitral Valve Repair for Secondary Mitral Regurgitation: A Systematic Review and Meta-Regression AnalysisMarco Zimarino, Fabrizio Ricci, Davide Capodanno, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 22, 2009
Real world safety and efficacy of the Janus Tacrolimus-Eluting stent: long-term clinical outcome and angiographic findings from the Tacrolimus-Eluting STent (TEST) registryCorrado Tamburino, Maria Elena Di Salvo, Davide Capodanno, et al.
The American Journal of Cardiology|March 10, 2017
A Risk Model for Prediction of 1-Year Mortality in Patients Undergoing MitraClip ImplantationSergio Buccheri, Davide Capodanno, Marco Barbanti, et al.
Pageof 108